Lv6
2480 积分 2024-11-08 加入
Good CARMA: Turning bad tumor‐resident myeloid cells good with chimeric antigen receptor macrophages
5个月前
已完结
Extending the In Vivo Residence Time of Macrophage Membrane‐Coated Nanoparticles through Genetic Modification
5个月前
已完结
X‐ray‐Guided In Situ Genetic Engineering of Macrophages for Sustained Cancer Immunotherapy
5个月前
已完结
Reprogramming Tumor-Associated Macrophage by Ornithine Decarboxylase Inhibitor and Immune Checkpoint for Orthotopic Glioblastoma Photothermal Immunotherapy
5个月前
已完结
Dynamic conformational states of apo, ATP and cabozantinib bound TAM kinases to differentiate active-inactive kinetic models
5个月前
已完结
Discovery of a Novel CSF-1R Inhibitor with Highly Improved Pharmacokinetic Profiles and Superior Efficacy in Colorectal Cancer Immunotherapy
5个月前
已完结
The role of tumor‐associated macrophages in hepatocellular carcinoma—from bench to bedside: A review
5个月前
已完结
Origin, production and molecular determinants of macrophages for their therapeutic targeting
5个月前
已完结
Multi-omics pan-cancer analysis of monocyte to macrophage differentiation-associated (MMD) and its significance in hepatocellular carcinoma
5个月前
已完结
Efferocytosis Nanoinhibitors to Promote Secondary Necrosis and Potentiate the Immunogenicity of Conventional Cancer Therapies for Improved Therapeutic Benefits
5个月前
已完结
皖公网安备34019202002308
